A 50 kDa protein present in conditioned medium of COLO-16 cells stimulates cell spreading and motility, and activates tyrosine phosphorylation of Neu/HER-2, in human SK-BR-3 mammary cancer cells

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by De Corte, V.
	Articles by Vandekerckhove, J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by De Corte, V.
	Articles by Vandekerckhove, J.


Social Bookmarking

	What's this?

Baumann, H., Jahreis, G. P., Sauder, D. N. and Koj, A (1984). Human keratinocytes and monocytes release factors which regulate the synthesis of major acute phase plasma proteins in hepatic cells from man, rat, and mouse. J. Biol. Chem 259, 7331-7342.[Abstract/Free Full Text]

Bernstein, J. J., Anagnostopoulos, A. V., Hattwick, B. S., Hattwick, E. A. and Laws, E. R. Jr (1993). Human-specific c-neu proto-oncogene protein overexpression in human malignant astrocytomas before and after xenografting. J. Neurosurg 78, 240-251.[Medline]

Bracke, M. E., Van Larebeke, N. A., Vyncke, B. M. and Mareel, M. M (1991). Retinoic acid modulates both invasion and plasma membrane ruffling of MCF-7 human mammary carcinoma cells in vitro. Br. J. Cancer 63, 867-872.[Medline]

Carothers Carraway, C. A., Carvajal, M. E., Li, Y. and Carraway, K. L (1993). Association of p185neuwith microfilaments via a large glycoprotein complex in mammary carcinoma microvilli. J. Biol. Chem 268, 5582-5587.[Abstract/Free Full Text]

Connelly, P. A. and Stern, D. F (1990). The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade. Proc. Nat. Acad. Sci. USA 87, 6054-6057.[Abstract/Free Full Text]

Corbett, I. P., Henry, J. A., Angus, B., Watchorn, C. J., Wilkinson, L., Hennessy, C., Gullick, W. J., Tuzi, N. L., May, F. E. B., Westley, B. R. and Horne, C. H. W (1990). NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue. J. Pathol 161, 15-25.[Medline]

Dati, C., Antoniotti, S., Taverna, D., Perroteau, I. and De Bortoli, M (1990). Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells. Oncogene 5, 1001-1006.[Medline]

De Potter, C. R., Quatacker, J., Maertens, G., Van Daele, S., Pauwels, C., Verhofstede, W., Eechaute, W. and Roels, H (1989). The subcellular localization of the neu protein in human normal and neoplastic cells. Int. J. Cancer 44, 969-974.[Medline]

De Potter, C. R., Van Daele, S., Van de Vijver, M. J., Pauwels, C., Maertens, G., De Boever, J., Vandekerckhove, D. and Roels, H (1989). The expression of the neu -oncogene product in normal fetal and adult human tissues. Histopathology 15, 351-362.[Medline]

Dobashi, K., Davis, J. G., Mikami, Y., Freeman, J. K., Hamuro, J. and M. I. Greene (1991). Characterization of a neu/c-erbB-2 protein-specific activating factor. Proc. Nat. Acad. Sci. USA 88, 8582-8586.[Abstract/Free Full Text]

Eaton, D. L., Wood, W. I., Eaton, D., Hass, P. E., Hollingshead, P., Wion, K., Mather, J., Lawn, R. M., Vehar, G. A. and Gorman, C (1986). Construction and characterization of an active factor VIII variant lacking the central one third of the molecule. Biochemistry 25, 8343-8347.[Medline]

Falls, D. L., Rosen, K. M., Corfas, G., Lane, W. S. and Fischbach, G. D (1993). ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the Neu ligand family. Cell 72, 801-815.[Medline]

Holmes, W. E., Sliwkowski, M. X., Akita, R. W., Henzel, W. J., Lee, J., Park, J. W., Yansura, D., Abadi, N., Raab, H., Lewis, G. D., Shepard, H. M., Kuang, W.-J., Wood, W. I., Goeddel, D. V. and Vandlen R. L (1992). Idenfication of heregulin, a specific activator of p185erbB2. Science 256, 1205-1210.[Abstract/Free Full Text]

Huang, S. S. and Huang, J. S (1992). Purification and characterization of the neu/erb-B2 ligand-growth factor from bovine kidney. J. Biol. Chem 267, 11508-11512.[Abstract/Free Full Text]

Hudziak, R. M., Schlessinger, J. and Ullrich, A (1987). Increased expression of the putative growth factor receptor p185HER2causes transformation and tumor genesis of NIH3T3 cells. Proc. Nat. Acad. Sci. USA 84, 7159-7163.[Abstract/Free Full Text]

King, C. R., Kraus, M. H. and Aaronson, S. A (1985). Amplification of a novel v- erbB -related gene in a human mammary carcinoma. Science 229, 974-976.[Abstract/Free Full Text]

Kokai, Y., Dobashi, K., Weiner, D. B., Myers, J. N., Nowell, P. C. and Greene, M. I (1988). Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products. Proc. Nat. Acad. Sci. USA 85, 5389-5393.[Abstract/Free Full Text]

Kraus, M. H., Popescu, N. C., Amsbaugh, S. C. and King, C. R (1987). Overexpression of the EGF receptor-related proto-oncogene erb B-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 6, 605-610.[Medline]

Lupu, R., Colomer, R., Zugmaier, G., Sarup, J., Shepard, M., Slamon, D. and Lippman, M. E (1990). Direct interaction of a ligand for the erb B-2 oncogene product with the EGF receptor and p185 erb B2. Science 249, 1552-1555.[Abstract/Free Full Text]

Lupu, R., Ramon, C., Kannan, B. and Lippman, M. E (1992). Characterization of a growth factor that binds exclusively to the erb B-2 receptor and induces cellular responses. Proc. Nat. Acad. Sci. USA 89, 2287-2291.[Abstract/Free Full Text]

Maguire, H. C. Jr, Jaworsky, C., Cohen, J. A., Hellman, M., Weiner, D. B. and Greene, M. I (1989). Distribution of neu (c- erb B-2) protein in human skin. J. Invest. Dermatol 89, 786-790.

Marchionni, M. A., Goodearl, A. D. J., Chen M. S., Bermingham-McDonogh, O., Kirk, C., Hendricks, M., Danehy, F., Misumi, D., Sudhalter, J., Kobayashi, K., Wroblewski, D., Lynch, C., Baldassare, M., Hiles, I., Davis, J. B., Hsuan, J. J., Totty, N. F., Otsu, M., McBurney, R. N., Waterfield, M. D., Stroobant, P. and Gwynne, D (1993). Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature 362, 312-318.[Medline]

Mareel, M. M., Van Roy, F. M. and De Baetselier, P (1990). The invasive phenotypes. Cancer Metast. Rev 9, 45-62.[Medline]

Matsudaira, P. and Burgess, K (1984). SDS microslab lineair gradient gel electrophoresis. Anal. Biochem 87, 386-396.

Moore, G. E., Merrick, S. B., Woods, L. K. and Arabasz, N. M (1975). A human squamous cell carcinoma cell line. Cancer Res 35, 2684-2688.[Abstract/Free Full Text]

Mosmann, T (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth 65, 55-63.[Medline]

Noguchi, M., Murakami, M., Bennett, W., Lupu, R., Hui, F., Harris, C. C. Jr and Gerwin, B. I (1993). Biological consequences of overexpression of a transfected c- erb B-2 Gene in immortalized human bronchial epithelial cells. Cancer Res 53, 2035-2043.[Abstract/Free Full Text]

Peles, E., Bacus, S. S., Koski, R. A., Lu, H. S., Wen, D., Ogden, S. G., Ben Levy, R. and Yarden, Y (1992). Isolation of the neu/HER-2 stimulatory ligand: a 44kD glycoprotein that induces differentiation of mammary tumor cells. Cell 69, 205-216.[Medline]

Peles, E., Ben Levy, R., Tzahar, E., Liu, N., Wen, D. and Yarden, Y (1993). Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships. EMBO J 12, 961-971.[Medline]

Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A. and McGuire, W. L (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-2/ neu oncogene. Science 235, 177-182.[Abstract/Free Full Text]

Sporn, M. B. and Roberts, A. B (1988). Peptide growth factors are multifunctional. Nature 332, 217-219.[Medline]

Stoker, M. and Gherardi, E (1991). Regulation of cell movement: the motogenic cytokines. Biochim. Biophys. Acta 1072, 81-102.[Medline]

Styles, J. M., Harrison, S., Gusterson, B. A. and Dean, C. J (1990). Rat monoclonal antibodies to the external domain of the product of the c-erbB-2 proto-oncogene. Int. J. Cancer 45, 320-.[Medline]

Tada, H., Shiho, O., Kuroshima, K.-i., Koyama, M. and Tsukamoto, K (1986). An improved colorimetric assay for interleukin 2. J. Immunol. Methods 93, 157-165.[Medline]

Tarakhovsky, A., Zaichuk, T., Prassolov, V. and Butenko, Z. A (1991). A25 kDa polypeptide is the ligand for p185neu and is secreted by activated macrophages. Oncogene 6, 2187-2196.[Medline]

Towbin, H., Staehelin, T. and Gordon, J (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Nat. Acad. Sci. USA 76, 4350-4354.[Abstract/Free Full Text]

Van de Vijver, M. J., Peterse, J. L., Mooi, W. J., Wisman, P., Lomans, J., Dalesio, O. and Nusse, R (1988). Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N. Engl. J. Med 319, 1239-1245.[Abstract]

Van Larebeke, N. A. F., Bracke, M. E. and Mareel, M. M (1992). Simple method for quantification of fast plasma membrane movements. Cytometry 13, 1-8.[Medline]

Van Larebeke, N. A. F., Bracke, M. E. and Mareel, M. M (1992). Invasive epithelial cells show more fast plasma membrane movements than related or parental non-invasive cells. Cytometry 13, 9-14.[Medline]

Vara, J. A., Portela, A., Ortin, J. and Jimenez, A (1986). Expression in mammalian cells of a gene from Streptomyces alboniger conferring puromycin resistance. Nucl. Acids Res 14, 4617-4624.[Abstract/Free Full Text]

Verhasselt, B., Coopman, P. and Mareel, M (1990). A modified chemoinvasion assay with increased sensitivity and specificity. Eur. J. Cell Biol 53, 31-.

Verhasselt, B., Van Damme, J., Van Larebeke, N., Put, W., Bracke, M., De Potter, C., Mareel, M (1992). Interleukin-1 is a motility factor for humanbreast carcinoma cells in vitro: additive effect with interleukin-6. Eur. J. Cell Biol 59, 449-457.[Medline]

Verschueren, H. and Van Larebeke, N (1984). A new model for the quantitative analysis of cell movement in vitro: definition of a shape change factor. Cytometry 5, 557-561.[Medline]

Wen, D., Peles, E., Cupples, R., Suggs, S. V., Bacus, S. S., Luo, Y., Trail, G., Hu, S., Silbiger, S. M., Ben Levy, R., Koski, R. A., Lu, H. S. and Yarden, Y (1992). Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell 69, 559-572.[Medline]

Wigler, M., Pellicer, A., Silverstein, S. and Axel, R (1978). Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell 14, 725-731.[Medline]

Yarden, Y. and Weinberg, R. A (1989). Experimental approaches to hypothetical hormones: detection of a candidate ligand of the neu protooncogene. Proc. Nat. Acad. Sci. USA 86, 3179-3183.[Abstract/Free Full Text]

Yarden, Y. and Peles, E (1991). Biochemical analysis of the ligand for the neu oncogenic receptor. Biochemistry 30, 3543-3550.[Medline]

Zigmond, S. H. and Hirsch, J. G (1973). Leucocyte locomotion and chemotaxis: new method for evaluation and demonstration of cell-derived chemotactic factor. J. Exp. Med 173, 387-410.

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati

Twitter What's this?

This article has been cited by other articles:

J. G. Christensen, R. E. Schreck, E. Chan, X. Wang, C. Yang, L. Liu, J. Cui, L. Sun, J. Wei, J. M. Cherrington, et al.
High Levels of HER-2 Expression Alter the Ability of Epidermal Growth Factor Receptor (EGFR) Family Tyrosine Kinase Inhibitors to Inhibit EGFR Phosphorylation in Vivo
Clin. Cancer Res., December 1, 2001; 7(12): 4230 - 4238.
[Abstract] [Full Text] [PDF]

V. R. J. Schelfhout, E. D. Coene, B. Delaey, S. Thys, D. L. Page, and C. R. De Potter
Pathogenesis of Paget's Disease: Epidermal Heregulin-{alpha}, Motility Factor, and the HER Receptor Family
J Natl Cancer Inst, April 19, 2000; 92(8): 622 - 628.
[Abstract] [Full Text] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by De Corte, V.

Articles by Vandekerckhove, J.

Search for Related Content

PubMed

PubMed Citation

Articles by De Corte, V.

Articles by Vandekerckhove, J.

Social Bookmarking

What's this?

				V. R. J. Schelfhout, E. D. Coene, B. Delaey, S. Thys, D. L. Page, and C. R. De Potter Pathogenesis of Paget's Disease: Epidermal Heregulin-{alpha}, Motility Factor, and the HER Receptor Family J Natl Cancer Inst, April 19, 2000; 92(8): 622 - 628. [Abstract] [Full Text] [PDF]